Pulmonary manifestations of chronic granulomatous disease

References

• Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. AMA J. Dis. Child. 97(4), 387–408 (1959).
   PubMedGoogle Scholar
• Segal BH, Leto TL, Gallin JI, Malech HL, Holland SM. Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine 79(3), 170–200 (2000).
   PubMed Web of Science ®Google Scholar
• Winkelstein JA, Marino MC, Johnston RB Jr et al. Chronic granulomatous disease. report on a national registry of 368 patients. Medicine (Baltimore) 79(3), 155–169 (2000).
   PubMed Web of Science ®Google Scholar
• Liese JG, Jendrossek V, Jansson A et al. Chronic granulomatous disease in adults. Lancet 347(8996), 220–223 (1996).
   PubMed Web of Science ®Google Scholar
• Matute JD, Arias AA, Wright NA et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood 114(15), 3309–3315 (2009).
   PubMed Web of Science ®Google Scholar
• Kuhns DB, Alvord WG, Heller T et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N. Engl. J. Med. 363(27), 2600–2610 (2010).
   PubMed Web of Science ®Google Scholar
• Fattahi F, Badalzadeh M, Sedighipour L et al. Inheritance pattern and clinical aspects of 93 Iranian patients with chronic granulomatous disease. J. Clin. Immunol. 31(5), 792–801 (2011).
   PubMed Web of Science ®Google Scholar
• Rezaei N, Pourpak Z, Aghamohammadi A et al. Consanguinity in primary immunodeficiency disorders; the report from Iranian Primary Immunodeficiency Registry. Am. J. Reprod. Immunol. 56(2), 145–151 (2006).
   PubMed Web of Science ®Google Scholar
• Kang EM, Marciano BE, DeRavin S, Zarember KA, Holland SM, Malech HL. Chronic granulomatous disease: overview and hematopoietic stem cell transplantation. J. Allergy Clin. Immunol. 127(6), 1319–26; quiz 1327 (2011).
   PubMed Web of Science ®Google Scholar
• Martire B, Rondelli R, Soresina A et al.; IPINET. Clinical features, long-term follow-up and outcome of a large cohort of patients with chronic granulomatous disease: an Italian multicenter study. Clin. Immunol. 126(2), 155–164 (2008).
   PubMed Web of Science ®Google Scholar
• Movahedi M, Aghamohammadi A, Rezaei N et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int. Arch. Allergy Immunol. 134(3), 253–259 (2004).
   PubMed Web of Science ®Google Scholar
• Norouzi S, Aghamohammadi A, Mamishi S, Rosenzweig SD, Rezaei N. Bacillus Calmette–Guérin (BCG) complications associated with primary immunodeficiency diseases. J. Infect. 64(6), 543–554 (2012).
   PubMed Web of Science ®Google Scholar
• Marciano BE, Rosenzweig SD, Kleiner DE et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics 114(2), 462–468 (2004).
   PubMed Web of Science ®Google Scholar
• Mansouri D, Adimi P, Mirsaedi M et al. Primary immune deficiencies presenting in adults: seven years of experience from Iran. J. Clin. Immunol. 25(4), 385–391 (2005).
   PubMed Web of Science ®Google Scholar
• van den Berg JM, van Koppen E, Ahlin A et al. Chronic granulomatous disease: the European experience. PLoS ONE 4(4), e5234 (2009).
   PubMed Web of Science ®Google Scholar
• Carnide EG, Jacob CA, Castro AM, Pastorino AC. Clinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients. Pediatr. Allergy Immunol. 16(1), 5–9 (2005).
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Murayama S, Takanashi S et al. Clinical features and prognoses of 23 patients with chronic granulomatous disease followed for 21 years by a single hospital in Japan. Eur. J. Pediatr. 167(12), 1389–1394 (2008).
   PubMed Web of Science ®Google Scholar
• Liese J, Kloos S, Jendrossek V et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J. Pediatr. 137(5), 687–693 (2000).
   PubMed Web of Science ®Google Scholar
• Godoy MC, Vos PM, Cooperberg PL, Lydell CP, Phillips P, Müller NL. Chest radiographic and CT manifestations of chronic granulomatous disease in adults. AJR Am. J. Roentgenol. 191(5), 1570–1575 (2008).
   PubMed Web of Science ®Google Scholar
• Khanna G, Kao SC, Kirby P, Sato Y. Imaging of chronic granulomatous disease in children. Radiographics 25(5), 1183–1195 (2005).
   PubMed Web of Science ®Google Scholar
• Johnston RB Jr. Clinical aspects of chronic granulomatous disease. Curr. Opin. Hematol. 8(1), 17–22 (2001).
   PubMed Web of Science ®Google Scholar
• Almyroudis NG, Holland SM, Segal BH. Invasive aspergillosis in primary immunodeficiencies. Med. Mycol. 43(Suppl. 1), S247–S259 (2005).
   PubMed Web of Science ®Google Scholar
• Marciano BE, Wesley R, De Carlo ES et al. Long-term interferon-gamma therapy for patients with chronic granulomatous disease. Clin. Infect. Dis. 39(5), 692–699 (2004).
   PubMed Web of Science ®Google Scholar
• Segal BH, DeCarlo ES, Kwon-Chung KJ, Malech HL, Gallin JI, Holland SM. Aspergillus nidulans infection in chronic granulomatous disease. Medicine 77(5), 345–354 (1998).
   PubMed Web of Science ®Google Scholar
• Dorman SE, Guide SV, Conville PS et al. Nocardia infection in chronic granulomatous disease. Clin. Infect. Dis. 35(4), 390–394 (2002).
   PubMed Web of Science ®Google Scholar
• Lacy DE, Spencer DA, Goldstein A, Weller PH, Darbyshire P. Chronic granulomatous disease presenting in childhood with Pseudomonas cepacia septicaemia. J. Infect. 27(3), 301–304 (1993).
   PubMed Web of Science ®Google Scholar
• Reichenbach J, Lopatin U, Mahlaoui N et al. Actinomyces in chronic granulomatous disease: an emerging and unanticipated pathogen. Clin. Infect. Dis. 49(11), 1703–1710 (2009).
   PubMed Web of Science ®Google Scholar
• Vinh DC, Shea YR, Sugui JA et al. Invasive aspergillosis due to Neosartorya udagawae. Clin. Infect. Dis. 49(1), 102–111 (2009).
   PubMed Web of Science ®Google Scholar
• Lee PP, Chan KW, Jiang L et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr. Infect. Dis. J. 27(3), 224–230 (2008).
   PubMed Web of Science ®Google Scholar
• Bustamante J, Aksu G, Vogt G et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J. Allergy Clin. Immunol. 120(1), 32–38 (2007).
   PubMed Web of Science ®Google Scholar
• Kuijpers T, Lutter R. Inflammation and repeated infections in CGD: two sides of a coin. Cell. Mol. Life Sci. 69(1), 7–15 (2012).
   PubMed Web of Science ®Google Scholar
• De Ravin SS, Naumann N, Cowen EW et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J. Allergy Clin. Immunol. 122(6), 1097–1103 (2008).
   PubMed Web of Science ®Google Scholar
• Tafti SF, Tabarsi P, Mansouri N et al. Chronic granulomatous disease with unusual clinical manifestation, outcome, and pattern of inheritance in an Iranian family. J. Clin. Immunol. 26(3), 291–296 (2006).
   PubMed Web of Science ®Google Scholar
• Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J. Exp. Med. 185(2), 207–218 (1997).
   PubMed Web of Science ®Google Scholar
• Siddiqui S, Anderson VL, Hilligoss DM et al. Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. Clin. Infect. Dis. 45(6), 673–681 (2007).
   PubMed Web of Science ®Google Scholar
• Brown KL, Bylund J, MacDonald KL et al. ROS-deficient monocytes have aberrant gene expression that correlates with inflammatory disorders of chronic granulomatous disease. Clin. Immunol. 129(1), 90–102 (2008).
   PubMed Web of Science ®Google Scholar
• Segal BH, Han W, Bushey JJ et al. NADPH oxidase limits innate immune responses in the lungs in mice. PLoS ONE 5(3), e9631 (2010).
   PubMed Web of Science ®Google Scholar
• De Ravin SS, Naumann N, Robinson MR et al. Sarcoidosis in chronic granulomatous disease. Pediatrics 117(3), e590–e595 (2006).
   Web of Science ®Google Scholar
• Foster CB, Lehrnbecher T, Mol F et al. Host defense molecule polymorphisms influence the risk for immune-mediated complications in chronic granulomatous disease. J. Clin. Invest. 102(12), 2146–2155 (1998).
   PubMed Web of Science ®Google Scholar
• Khalilzadeh S, Bloorsaz MR, Mansouri D, Baghaie N, Hakimi S, Velayati AA. Clinical and radiological aspects of chronic granulomatous disease in children: a case series from Iran. Iran. J. Allergy. Asthma. Immunol. 5(2), 85–88 (2006).
   PubMedGoogle Scholar
• Weening RS, Kabel P, Pijman P, Roos D. Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease. J. Pediatr. 103(1), 127–130 (1983).
   PubMed Web of Science ®Google Scholar
• Margolis DM, Melnick DA, Alling DW, Gallin JI. Trimethoprim-sulfamethoxazole prophylaxis in the management of chronic granulomatous disease. J. Infect. Dis. 162(3), 723–726 (1990).
   PubMed Web of Science ®Google Scholar
• Petropoulou T, Liese J, Tintelnot K, Gahr M, Belohradsky BH. Long-term treatment of patients with itraconazole for the prevention of Aspergillus infections in patients with chronic granulomatous disease (CGD). Mycoses 37(Suppl. 2), 64–69 (1994).
   PubMed Web of Science ®Google Scholar
• Holland SM. Chronic granulomatous disease. Clin. Rev. Allergy Immunol. 38(1), 3–10 (2010).
   PubMed Web of Science ®Google Scholar
• Uzel G, Orange JS, Poliak N, Marciano BE, Heller T, Holland SM. Complications of tumor necrosis factor-a blockade in chronic granulomatous disease-related colitis. Clin. Infect. Dis. 51(12), 1429–1434 (2010).
   PubMed Web of Science ®Google Scholar
• Yamazaki-Nakashimada MA, Stiehm ER, Pietropaolo-Cienfuegos D, Hernandez-Bautista V, Espinosa-Rosales F. Corticosteroid therapy for refractory infections in chronic granulomatous disease: case reports and review of the literature. Ann. Allergy Asthma Immunol. 97(2), 257–261 (2006).
   PubMed Web of Science ®Google Scholar
• Seger RA, Gungor T, Belohradsky BH et al. Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985–2000. Blood 100(13), 4344–4350 (2002).
   PubMed Web of Science ®Google Scholar
• Grez M, Reichenbach J, Schwäble J, Seger R, Dinauer MC, Thrasher AJ. Gene therapy of chronic granulomatous disease: the engraftment dilemma. Mol. Ther. 19(1), 28–35 (2011).
   PubMed Web of Science ®Google Scholar
• Ott MG, Schmidt M, Schwarzwaelder K et al. Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. Nat. Med. 12(4), 401–409 (2006).
   PubMed Web of Science ®Google Scholar
• Kang EM, Choi U, Theobald N et al. Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. Blood 115(4), 783–791 (2010).
   PubMed Web of Science ®Google Scholar
• Aiuti A, Slavin S, Aker M et al. Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296(5577), 2410–2413 (2002).
   PubMed Web of Science ®Google Scholar
• Cale CM, Jones AM, Goldblatt D. Follow up of patients with chronic granulomatous disease diagnosed since 1990. Clin. Exp. Immunol. 120(2), 351–355 (2000).
   PubMed Web of Science ®Google Scholar
• De Ravin SS, Naumann N, Cowen EW et al. Chronic granulomatous disease as a risk factor for autoimmune disease. J. Allergy Clin. Immunol. 122(6), 1097–1103 (2008).
   PubMed Web of Science ®Google Scholar
• Guide SV, Stock F, Gill VJ et al. Reinfection, rather than persistent infection, in patients with chronic granulomatous disease. J. Infect. Dis. 187(5), 845–853 (2003).
   PubMed Web of Science ®Google Scholar
• Carnide EG, Jacob CA, Castro AM, Pastorino AC. Clinical and laboratory aspects of chronic granulomatous disease in description of eighteen patients. Pediatr. Allergy Immunol. 16(1), 5–9 (2005).
   PubMed Web of Science ®Google Scholar
• Lekstrom-Himes JA, Kuhns DB, Alvord WG, Gallin JI. Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease. J. Immunol. 174(1), 411–417 (2005).
   PubMed Web of Science ®Google Scholar
• van de Veerdonk FL, Smeekens SP, Joosten LA et al. Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 107, 3030–3033 (2010).
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Iwai K, Yachie A et al. Involvement of reactive oxygen intermediates in spontaneous and CD95 (Fas/APO-1)-mediated apoptosis of neutrophils. Blood 89(5), 1748–1753 (1997).
   PubMed Web of Science ®Google Scholar
• Jones LB, McGrogan P, Flood TJ et al. Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry. Clin. Exp. Immunol. 152(2), 211–218 (2008).
   PubMed Web of Science ®Google Scholar